openPR Logo
Press release

Global Intrauterine Contraceptive Devices Market Surges as Demand for Long-Term, Hormone-Free Birth Control Rises 2025 | Top key players - Bayer, Pregna, Sebela Pharmaceuticals

06-17-2025 07:15 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Intrauterine Contraceptive Devices Market

Intrauterine Contraceptive Devices Market

The Intrauterine Contraceptive Devices (IUD) Market reached US$ 4.56 Billion in 2024 and is expected to reach US$ 6.92 Billion by 2033, growing at a CAGR of 4.8% during the forecast period 2025-2033.

The Intrauterine Contraceptive Devices Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their product portfolios, pricing models, financial performance, growth initiatives, and regional presence.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/intrauterine-contraceptive-devices-market?sz

The Intrauterine Contraceptive Devices (IUCD) Market refers to the global industry focused on the development, production, and distribution of T-shaped, small, flexible birth control devices inserted into the uterus to prevent pregnancy. These devices, both hormonal and non-hormonal (copper-based), offer long-term, reversible contraception and are widely used due to their effectiveness, convenience, and minimal maintenance requirements.

Major players in the Intrauterine Contraceptive Devices Market

The prominent players in Intrauterine Contraceptive Devices market research report are: Teva Pharmaceuticals, Bayer, Pregna, Sebela Pharmaceuticals, CooperSurgical, Inc., AbbVie, Eurogine, and SMB Corporation, among others.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Key Development

In February 2025, Sebela Women's Health Inc., a division of Sebela Pharmaceuticals, received a major milestone with FDA approval for MIUDELLA a new, hormone-free copper intrauterine device (IUD) designed to prevent pregnancy for up to three years. This next-generation, low-dose IUD is the first of its kind to gain FDA approval in over four decades, marking a significant advancement in non-hormonal birth control options.

In July 2024, 3Daughters a company focused on transforming women's healthcare successfully closed an oversubscribed seed funding round, raising $4.7 million. The round included continued support from Thairm Bio, Argosy Foundation, Wexford Science and Technology, UMass Amherst, and several new undisclosed investors, helping fuel the company's mission to innovate in reproductive health.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/intrauterine-contraceptive-devices-market

Market Segments

By Type: Hormonal IUD, Copper IUD.

By End-User: Hospitals, Gynecology Clinics, Community Healthcare Centers, Others.

The Intrauterine Contraceptive Devices industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Intrauterine Contraceptive Devices Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Stay ahead with data-driven strategies, competitive analysis, and future outlook.
👉 Get the Extensive Full Report Now: https://www.datamintelligence.com/buy-now-page?report=intrauterine-contraceptive-devices-market?sz

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Intrauterine Contraceptive Devices Market Surges as Demand for Long-Term, Hormone-Free Birth Control Rises 2025 | Top key players - Bayer, Pregna, Sebela Pharmaceuticals here

News-ID: 4069353 • Views:

More Releases from DataM Intelligence 4Market Research

United States Peripheral Neuropathy Market Set for Transformative Growth with Rising Treatment Innovations 2025 | Top key players - GlaxoSmithKline, Abbott Laboratories, Cipla Laboratories.
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth: The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031). The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancements in Treatment & Rising Cardiovascular Cases 2025 | Top key players - Merck, Novartis, Amgen Inc.
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth: The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031. The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - AdvaCare Pharma, Sanofi, Pfizer Inc.
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth: The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033. The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth with Innovative Therapies Revolutionizing Oncology Care 2025 | Major key players - BioNTech SE, Merck & Co., Inc., Moderna, Inc.
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth: The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033. The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in

All 5 Releases


More Releases for Intrauterine

Primary Catalyst Driving Intrauterine Devices Market Evolution in 2025: Rising U …
What combination of drivers is leading to accelerated growth in the intrauterine devices market? The surge in unplanned pregnancies is predicted to boost the intrauterine devices market's growth. Unplanned pregnancies refer to either unwanted or unplanned pregnancies, such as situations where no more children are wished for. Intrauterine devices (IUDs) are highly effective in birth control, as they alter the environment of the uterus, making it inappropriate for sperm to fertilize
Primary Catalyst Driving Intrauterine Devices Market Evolution in 2025: Rising U …
What combination of drivers is leading to accelerated growth in the intrauterine devices market? The surge in unplanned pregnancies is predicted to boost the intrauterine devices market's growth. Unplanned pregnancies refer to either unwanted or unplanned pregnancies, such as situations where no more children are wished for. Intrauterine devices (IUDs) are highly effective in birth control, as they alter the environment of the uterus, making it inappropriate for sperm to fertilize
What's Driving the Intrauterine Devices Market 2025-2034: Rising Unplanned Pregn …
What Are the Projections for the Size and Growth Rate of the Intrauterine Devices Market? The intrauterine devices market will grow from $3.96 billion in 2024 to $4.17 billion in 2025, with a CAGR of 5.3%. The growth is driven by family planning initiatives, women's empowerment, long-acting reversible contraception (LARC), high contraceptive efficacy, cost-effectiveness, and healthcare professional advocacy. The Intrauterine Devices market will reach $4.94 billion by 2029 at a CAGR of
Global Intrauterine Devices Market Research Report 2023-2029
An intrauterine device (IUD) is a small contraceptive device that is put into the uterus (womb) to prevent pregnancy. The 2 types available in Australia are the copper IUD and the hormonal IUD (MirenaTM). The copper IUD is designed to stay in place for up to 10 years and the hormonal IUD (Mirena) for 5 years. Both can easily be removed sooner, if needed. Intrauterine Devices report published by QYResearch reveals
Intrauterine Insemination Devices Market - Embrace the Journey, Embrace Success: …
Newark, New Castle, USA - new report, titled Intrauterine Insemination Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Intrauterine Insemination Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Intrauterine Insemination Devices market. The report offers an overview of
Intrauterine Devices Market Growing Awareness Regarding Family Planning
According to Precision Business Insights (PBI), the latest report, the intrauterine devices market is expected to be valued at USD 3,476.4 million in 2022 and is poised to grow at a significant CAGR of 4.1% over 2022-2028. The primary driver of the expansion of the global Intrauterine Devices market rises in the occurrence of unintended pregnancies, with favourable government initiatives for spreading awareness regarding family planning, and encouraging the